Skip to main content
logo
MindMaze Therapeutics Holding SA (SWX:MMTX)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
0.1680
-0.0120 (-6.67%)
Sep 11, 2026, 5:30 PM CET

SWX:MMTX Financials Overview

Millions CHF. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024
Period EndingJun '26 Dec '25 Dec '24
Revenue
1.20.64-
Revenue Growth
---
Gross Profit
1.080.59-
Operating Income
-12.07-10.52-0
Net Income
-13.54-9.91-0
Earnings Per Share
-0.15-0.48-0.00
EPS Growth
---

Revenue by Geography
Chart
Fiscal YearFY 2025
Period EndingDec '25
Asia
0.26
USA
0.17
Europe (Excl. Switzerland)
0.14
Switzerland
0.06
Rest of The World
0.02
Total
0.64

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024
Period EndingJun '26 Dec '25 Dec '24
Cash & Investments
5.329.55-
Total Debt
0.021.81-
Net Cash (Debt)
5.37.74-
Net Cash Growth
---
Net Cash Per Share
0.060.38-

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024
Period EndingJun '26 Dec '25 Dec '24
Operating Cash Flow
-13.51-7.21-0
Capital Expenditures
-2.83-6.24-
Free Cash Flow
-16.34-13.45-0
Free Cash Flow Growth
---

Margins
Chart
Fiscal YearTTMFY 2025FY 2024
Period EndingJun '26 Dec '25 Dec '24
Gross Margin
90.39%92.06%-
Operating Margin
-1009.45%-1637.85%-
Pretax Margin
-782.44%-1542.99%-
Profit Margin
-1132.27%-1542.99%-
FCF Margin
-1365.89%-2094.39%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024
Period EndingSep '26 Dec '25 Dec '24
PS Ratio
23.88451.62-